The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Remifentanil Hydrochloride for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Remifentanil Hydrochloride for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1751651

No of Pages : 97

Ask Your Query

Synopsis
The global Remifentanil Hydrochloride for Injection market size was valued at USD 426 million in 2022 and is forecast to a readjusted size of USD 754.9 million by 2029 with a CAGR of 8.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Remifentanil Hydrochloride for Injection has analgesic effect. The main active ingredient is remifentanil, which belongs to opioid agonists. It exerts obvious analgesic effect by stimulating opioid receptors.

This report is a detailed and comprehensive analysis for global Remifentanil Hydrochloride for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Remifentanil Hydrochloride for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Remifentanil Hydrochloride for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Remifentanil Hydrochloride for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global Remifentanil Hydrochloride for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Remifentanil Hydrochloride for Injection
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Remifentanil Hydrochloride for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Nhua Pharmaceutical, Yichang Renfu Pharmaceutical, Sinopharm Group, Aspen and Fresenius Kab and etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Remifentanil Hydrochloride for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • 1mg/vial
  • 2mg/vial
  • 5mg/via

Market segment by Application

  • Hospital
  • Clinic

Major players covered

  • Jiangsu Nhua Pharmaceutical
  • Yichang Renfu Pharmaceutical
  • Sinopharm Group
  • Aspen
  • Fresenius Kab
  • Sandoz

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Remifentanil Hydrochloride for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Remifentanil Hydrochloride for Injection, with price, sales, revenue and global market share of Remifentanil Hydrochloride for Injection from 2018 to 2023.
Chapter 3, the Remifentanil Hydrochloride for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remifentanil Hydrochloride for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Remifentanil Hydrochloride for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Remifentanil Hydrochloride for Injection.
Chapter 14 and 15, to describe Remifentanil Hydrochloride for Injection sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Remifentanil Hydrochloride for Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Remifentanil Hydrochloride for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 1mg/vial
1.3.3 2mg/vial
1.3.4 5mg/via
1.4 Market Analysis by Application
1.4.1 Overview: Global Remifentanil Hydrochloride for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Remifentanil Hydrochloride for Injection Market Size & Forecast
1.5.1 Global Remifentanil Hydrochloride for Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Remifentanil Hydrochloride for Injection Sales Quantity (2018-2029)
1.5.3 Global Remifentanil Hydrochloride for Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Jiangsu Nhua Pharmaceutical
2.1.1 Jiangsu Nhua Pharmaceutical Details
2.1.2 Jiangsu Nhua Pharmaceutical Major Business
2.1.3 Jiangsu Nhua Pharmaceutical Remifentanil Hydrochloride for Injection Product and Services
2.1.4 Jiangsu Nhua Pharmaceutical Remifentanil Hydrochloride for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Jiangsu Nhua Pharmaceutical Recent Developments/Updates
2.2 Yichang Renfu Pharmaceutical
2.2.1 Yichang Renfu Pharmaceutical Details
2.2.2 Yichang Renfu Pharmaceutical Major Business
2.2.3 Yichang Renfu Pharmaceutical Remifentanil Hydrochloride for Injection Product and Services
2.2.4 Yichang Renfu Pharmaceutical Remifentanil Hydrochloride for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Yichang Renfu Pharmaceutical Recent Developments/Updates
2.3 Sinopharm Group
2.3.1 Sinopharm Group Details
2.3.2 Sinopharm Group Major Business
2.3.3 Sinopharm Group Remifentanil Hydrochloride for Injection Product and Services
2.3.4 Sinopharm Group Remifentanil Hydrochloride for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sinopharm Group Recent Developments/Updates
2.4 Aspen
2.4.1 Aspen Details
2.4.2 Aspen Major Business
2.4.3 Aspen Remifentanil Hydrochloride for Injection Product and Services
2.4.4 Aspen Remifentanil Hydrochloride for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aspen Recent Developments/Updates
2.5 Fresenius Kab
2.5.1 Fresenius Kab Details
2.5.2 Fresenius Kab Major Business
2.5.3 Fresenius Kab Remifentanil Hydrochloride for Injection Product and Services
2.5.4 Fresenius Kab Remifentanil Hydrochloride for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fresenius Kab Recent Developments/Updates
2.6 Sandoz
2.6.1 Sandoz Details
2.6.2 Sandoz Major Business
2.6.3 Sandoz Remifentanil Hydrochloride for Injection Product and Services
2.6.4 Sandoz Remifentanil Hydrochloride for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sandoz Recent Developments/Updates
3 Competitive Environment: Remifentanil Hydrochloride for Injection by Manufacturer
3.1 Global Remifentanil Hydrochloride for Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Remifentanil Hydrochloride for Injection Revenue by Manufacturer (2018-2023)
3.3 Global Remifentanil Hydrochloride for Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Remifentanil Hydrochloride for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Remifentanil Hydrochloride for Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Remifentanil Hydrochloride for Injection Manufacturer Market Share in 2022
3.5 Remifentanil Hydrochloride for Injection Market: Overall Company Footprint Analysis
3.5.1 Remifentanil Hydrochloride for Injection Market: Region Footprint
3.5.2 Remifentanil Hydrochloride for Injection Market: Company Product Type Footprint
3.5.3 Remifentanil Hydrochloride for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Remifentanil Hydrochloride for Injection Market Size by Region
4.1.1 Global Remifentanil Hydrochloride for Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Remifentanil Hydrochloride for Injection Consumption Value by Region (2018-2029)
4.1.3 Global Remifentanil Hydrochloride for Injection Average Price by Region (2018-2029)
4.2 North America Remifentanil Hydrochloride for Injection Consumption Value (2018-2029)
4.3 Europe Remifentanil Hydrochloride for Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Remifentanil Hydrochloride for Injection Consumption Value (2018-2029)
4.5 South America Remifentanil Hydrochloride for Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Remifentanil Hydrochloride for Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Remifentanil Hydrochloride for Injection Sales Quantity by Type (2018-2029)
5.2 Global Remifentanil Hydrochloride for Injection Consumption Value by Type (2018-2029)
5.3 Global Remifentanil Hydrochloride for Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Remifentanil Hydrochloride for Injection Sales Quantity by Application (2018-2029)
6.2 Global Remifentanil Hydrochloride for Injection Consumption Value by Application (2018-2029)
6.3 Global Remifentanil Hydrochloride for Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Remifentanil Hydrochloride for Injection Sales Quantity by Type (2018-2029)
7.2 North America Remifentanil Hydrochloride for Injection Sales Quantity by Application (2018-2029)
7.3 North America Remifentanil Hydrochloride for Injection Market Size by Country
7.3.1 North America Remifentanil Hydrochloride for Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Remifentanil Hydrochloride for Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Remifentanil Hydrochloride for Injection Sales Quantity by Type (2018-2029)
8.2 Europe Remifentanil Hydrochloride for Injection Sales Quantity by Application (2018-2029)
8.3 Europe Remifentanil Hydrochloride for Injection Market Size by Country
8.3.1 Europe Remifentanil Hydrochloride for Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Remifentanil Hydrochloride for Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Remifentanil Hydrochloride for Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Remifentanil Hydrochloride for Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Remifentanil Hydrochloride for Injection Market Size by Region
9.3.1 Asia-Pacific Remifentanil Hydrochloride for Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Remifentanil Hydrochloride for Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Remifentanil Hydrochloride for Injection Sales Quantity by Type (2018-2029)
10.2 South America Remifentanil Hydrochloride for Injection Sales Quantity by Application (2018-2029)
10.3 South America Remifentanil Hydrochloride for Injection Market Size by Country
10.3.1 South America Remifentanil Hydrochloride for Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Remifentanil Hydrochloride for Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Remifentanil Hydrochloride for Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Remifentanil Hydrochloride for Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Remifentanil Hydrochloride for Injection Market Size by Country
11.3.1 Middle East & Africa Remifentanil Hydrochloride for Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Remifentanil Hydrochloride for Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Remifentanil Hydrochloride for Injection Market Drivers
12.2 Remifentanil Hydrochloride for Injection Market Restraints
12.3 Remifentanil Hydrochloride for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Remifentanil Hydrochloride for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Remifentanil Hydrochloride for Injection
13.3 Remifentanil Hydrochloride for Injection Production Process
13.4 Remifentanil Hydrochloride for Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Remifentanil Hydrochloride for Injection Typical Distributors
14.3 Remifentanil Hydrochloride for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock